Predictive Significance of Serum Level of Vascular Endothelial Growth Factor in Gastric Cancer Patients

Table 1

Correlation of serum VEGF with clinical indicators in patients with gastric cancer (median (IQR)).

Parameters	Number	VEGF (pg/mL)	value
Gender
Male	112 (72.7%)	151.686 (143.640)	0.942
Female	42 (27.3%)	134.643 (154.517)
Age
≤60	70 (45.5%)	130.314 (140.753)	0.056
>60	84 (54.5%)	163.089 (163.860)
Differentiation degree
Low	92 (59.7%)	171.181 (158.886)	0.012
Moderate	58 (37.7%)	116.824 (104.379)
High	4 (2.6%)	163.360 (179.338)
Clinical stages
I+II	84 (54.5%)	121.702 (138.479)	0.004
III+IV	70 (45.5%)	173.823 (146.996)
Depth of infiltration
T1+T2	59 (38.3%)	110.770 (99.111)	0.004
T3+T4	95 (61.7%)	171.692 (158.016)
Lymph node metastasis
No	60 (39.0%)	122.274 (112.414)	0.036
Yes	94 (61%)	171.669 (149.365)
Distant metastasis
No	138 (89.6%)	145.812 (148.228)	0.854
Yes	16 (10.4%)	153.702 (113.545)
Lauren
Intestinal	64 (41.6%)	154.309 (149.211)	0.651
Diffuse	43 (27.9%)	135.712 (145.44)
Mixed	46 (29.9%)	155.912 (171.842)
Unknown	1 (0.6%)	149.933
HER2
Negative	70 (45.5%)	149.126 (137.971)	0.397
Positive	74 (48.1%)	137.630 (155.948)
Unknown	10 (6.4%)	151.686 (105.018)
EGFR
Negative	7 (4.5%)	99.352 (402.412)	0.708
Positive	127 (82.5%)	140.213 (143.821)
Unknown	20 (13.0%)	156.699 (108.166)
Tumor size
≤4 cm	89 (57.8%)	129.478 (141.868)	0.028
>4 cm	49 (31.8%)	169.255 (155.814)
Unknown	16 (10.4%)	130.409 (120.659)
Total	154 (100%)